InvestorsHub Logo
Followers 3420
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

Re: biolover post# 49267

Friday, 11/04/2011 2:15:16 AM

Friday, November 04, 2011 2:15:16 AM

Post# of 97239
AIS..$2.29 I think that Anturol will get approval. What could drag the stock down potentially is negative efficacy data for Libigel. Two separate catalyst events with the Anturol being more of a certainty than the data release.

Sheff's Station...All Aboard...Sign Up Here!

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.